G. Yee

Publications116
h-index28
Citations4,559
Highly Influential Citations134
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • A. Lipton
  • 457 Publications, 27,577 Citations
  • R. Storb
  • 1,383 Publications, 83,629 Citations
  • C. Buckner
  • 404 Publications, 37,182 Citations
  • E. Thomas
  • 701 Publications, 59,227 Citations
  • Publications
  • Influence
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.
PURPOSE To update the 2000 ASCO guidelines on the role of bisphosphonates in women with breast cancer and address the subject of bone health in these women. RESULTS For patients with plain… Expand
  • 937
  • 35
American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.
PURPOSE To determine clinical practice guidelines for the use of bisphosphonates in the prevention and treatment of lytic bone disease in multiple myeloma and to determine their respective role… Expand
  • 494
  • 15
American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.
PURPOSE To update the recommendations for the use of bisphosphonates in the prevention and treatment of bone disease in multiple myeloma. The Update Committee expanded the guideline to include a… Expand
  • 378
  • 14
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
PURPOSE: To determine clinical practice guidelines for the use of bisphosphonates in the prevention and treatment of bone metastases in breast cancer and their role relative to other therapies for… Expand
  • 384
  • 13
American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer.
PURPOSE To update the recommendations on the role of bone-modifying agents in the prevention and treatment of skeletal-related events (SREs) for patients with metastatic breast cancer with bone… Expand
  • 223
  • 9
  • PDF
Effect of grapefruit juice on blood cyclosporin concentration
Grapefruit juice increases blood concentrations of some dihydropyridine calcium-channel blockers, which are metabolised by the P450 enzymes that also metabolise cyclosporin. We evaluated, in a… Expand
  • 127
  • 9
Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer
Purpose To update the recommendations on the role of bone-modifying agents in the prevention and treatment of skeletal-related events (SREs) for patients with metastatic breast cancer with bone… Expand
  • 70
  • 5
  • PDF
Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.
To determine the relation between the serum cyclosporine concentration and the risk of acute graft-versus-host disease (GVHD), we studied 179 recipients of bone marrow grafts from HLA-identical… Expand
  • 115
  • 3
Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update.
Purpose To update guideline recommendations on the role of bone-modifying agents in multiple myeloma. Methods An update panel conducted a targeted systematic literature review by searching PubMed and… Expand
  • 46
  • 3
  • PDF
Book Review: Pharmacotherapy: A Pathophysiologic Approach, 7th Edition
CPNP members maintain a suggested reading list to provide information on peer recommended resources and convenient access to the highest quality neuropsychopharmacology publications. A reminder that… Expand
  • 19
  • 3